The Plasma Heir And The Marguerre Family
How a Heidelberg‑trained executive built Octapharma around human proteins — and folded a five‑child family into the ownership and boardroom of a multibillion‑dollar private drug empire.
The public record gives only a skeletal outline of the Marguerre clan: a marriage to Barbara, five children, and a statement that Octapharma is owned by Wolfgang and three of those children.[page:65] No names are given for the remaining two, underscoring how the family has kept most of the next generation outside searchable biographical detail.[page:65]
Two of the children, Frederic and Tobias Marguerre, are named as members of Octapharma’s management board, making them both heirs and executives inside the group.[page:65] This aligns the family’s economic interests and daily decision‑making authority, classic for a tightly held European pharma dynasty built around a single founder.[page:65]
The article specifies ownership as “Marguerre and his three children,” but only Frederic and Tobias appear on the management board, implying at least one additional child is a shareholder while staying out of operations and public view.[page:65]
Beyond this, the English‑language entry offers no genealogy: no birth years for the children, no hints at which of them studied at INSEAD or in Heidelberg, and no philanthropic foundations explicitly branded with the family name.[page:65] What it does detail instead is Wolfgang’s own path — political and economic science in Heidelberg, an MBA at INSEAD in 1972, and senior roles at Pharmaplast, Baxter‑Travenol and Revlon Healthcare before founding Octapharma in 1983.[page:65]
His philanthropic profile is personal but easily read as family soft‑power: sponsoring 70 children with bleeding disorders through Save One Life, helping to save the Heidelberg Theatre from closure and funding refugee integration in the city, gestures that all sit adjacent to Octapharma’s core business in coagulation and immunology.[page:65] When the theatre reopened in 2012, its new stage was named “Marguerre‑Saal,” fixing the surname into Heidelberg’s cultural architecture in the same way the company name sits on factories and vials.[page:65]
Forbes and Bloomberg profiles cited in the article estimate Marguerre’s net worth at just over US$5 billion as of late 2020, entirely tied to his stake in privately held Octapharma — meaning family ownership decisions directly determine the scale of the dynasty’s wealth.[page:65]
The Marguerre family runs a quiet but classic pharma dynasty: Wolfgang and Barbara at the top, five children beneath, three of them co‑owners and at least two — Frederic and Tobias — serving on Octapharma’s management board while the rest stay deliberately off‑stage.[page:65] With a billionaire founder whose name is on both a plasma‑medicine group and a Heidelberg theatre hall, the clan shows how modern European fortunes can be concentrated in a single private company that doubles as both business and family office, with only a thin slice of the genealogy visible to the outside world.[page:65]
The Biscuit And Billionaires Trust – Weston family
The Island Dynasty bettencourt family